CommBio Therapeutics
Latest round
- Angel
Last raised
- Nov 2019
Total raised
- Undisclosed
Investors
- 1
About CommBio Therapeutics
Based in Suzhou, China and established in 2019, CommBio Therapeutics operates as biopharmaceutical developer that focues on bacterial vector gene therapy. The company provides bacterial vector gene therapy and related products for patients such as phenylketonuria (PKU). The product of the company includes synb1618 and synb1934. The company will increase investment in researching and developing product and promote clinical projects.
Who invested in CommBio Therapeutics
1 investor across 1 round
See all investors in CommBio Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Angel
Nov 23, 2019
Amount
Undisclosed
Investors
Questions about CommBio Therapeutics
Who invested in CommBio Therapeutics?
CommBio Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CommBio Therapeutics raised?
CommBio Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CommBio Therapeutics last raise money?
CommBio Therapeutics's most recent round on record is a Angel, in Nov 2019.
What does CommBio Therapeutics do?
Based in Suzhou, China and established in 2019, CommBio Therapeutics operates as biopharmaceutical developer that focues on bacterial vector gene therapy.
Where is CommBio Therapeutics headquartered?
CommBio Therapeutics is headquartered in Suzhou, China.
Which VCs invest in companies like CommBio Therapeutics?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at CommBio Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like CommBio Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.